Zimmer Biomet Holdings Inc
NYSE:ZBH
Zimmer Biomet Holdings Inc
NYSE:ZBH
Price:
121.17 USD
-0.29%
Market Closed
Updated:
Apr 25, 2024
Zimmer Biomet Holdings Inc
Operating Income
Last
Value
3-Years CAGR
5-Years CAGR
|
Zimmer Biomet Holdings Inc
Operating Income Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Zimmer Biomet Holdings Inc
NYSE:ZBH
|
Operating Income
$1.5B
|
CAGR 3-Years
25%
|
CAGR 5-Years
2%
|
CAGR 10-Years
1%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Operating Income
$2.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
5%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Operating Income
$2.4B
|
CAGR 3-Years
39%
|
CAGR 5-Years
7%
|
CAGR 10-Years
10%
|
|
|
Stryker Corp
NYSE:SYK
|
Operating Income
$4.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Operating Income
$6.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Operating Income
$1.8B
|
CAGR 3-Years
16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
See Also
What is Zimmer Biomet Holdings Inc's Operating Income?
Operating Income
1.5B
USD
1.5B
USD
Based on the financial report for Dec 31, 2023, Zimmer Biomet Holdings Inc's Operating Income amounts to 1.5B USD.
What is Zimmer Biomet Holdings Inc's Operating Income growth rate?
Operating Income CAGR 10Y
1%
1%
Over the last year, the Operating Income growth was 20%. The average annual Operating Income growth rates for Zimmer Biomet Holdings Inc have been 25% over the past three years , 2% over the past five years , and 1% over the past ten years .
You don't have any saved screeners yet
